The Europe Urology Laser Market would witness market growth of 5.9% CAGR during the forecast period (2023-2031).
The Germany market dominated the Europe Urology Laser Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $114.8 million by 2031. The UK market is exhibiting a CAGR of 4.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.8% during (2024 - 2031).
Urology lasers treat bladder tumours, urethral strictures, and other conditions affecting the urinary tract. Laser therapy offers several advantages over traditional surgical methods, including minimal bleeding, reduced risk of complications, shorter hospital stays, and faster recovery times. As a result, these have become an integral part of modern urological practice, providing patients with safe and effective treatment options for a wide range of urological conditions.
Technological advancements in this technology have significantly enhanced the capabilities of these systems, leading to a broader range of procedures that can be performed with greater precision and efficiency. One key area of advancement is the development of more precise laser systems, which allow surgeons to target specific tissues with unprecedented accuracy. This precision is particularly beneficial in delicate urological procedures, where avoiding damage to surrounding healthy tissue is crucial.
The rising use of these systems in Europe is closely tied to several key factors, including the increasing prevalence of benign prostatic hyperplasia (BPH) and the demographic shift towards an aging population. According to the National Library of Medicine, in 2019, Central Europe reported 325.71 thousand cases of BPH, Western Europe had 907.71 thousand cases, and Eastern Europe had 904.12 thousand cases. As a result, the expansion of the market in Europe is propelled by the demographic shift toward an aging population and the rising incidence of BPH.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Urology Laser Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $114.8 million by 2031. The UK market is exhibiting a CAGR of 4.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.8% during (2024 - 2031).
Urology lasers treat bladder tumours, urethral strictures, and other conditions affecting the urinary tract. Laser therapy offers several advantages over traditional surgical methods, including minimal bleeding, reduced risk of complications, shorter hospital stays, and faster recovery times. As a result, these have become an integral part of modern urological practice, providing patients with safe and effective treatment options for a wide range of urological conditions.
Technological advancements in this technology have significantly enhanced the capabilities of these systems, leading to a broader range of procedures that can be performed with greater precision and efficiency. One key area of advancement is the development of more precise laser systems, which allow surgeons to target specific tissues with unprecedented accuracy. This precision is particularly beneficial in delicate urological procedures, where avoiding damage to surrounding healthy tissue is crucial.
The rising use of these systems in Europe is closely tied to several key factors, including the increasing prevalence of benign prostatic hyperplasia (BPH) and the demographic shift towards an aging population. According to the National Library of Medicine, in 2019, Central Europe reported 325.71 thousand cases of BPH, Western Europe had 907.71 thousand cases, and Eastern Europe had 904.12 thousand cases. As a result, the expansion of the market in Europe is propelled by the demographic shift toward an aging population and the rising incidence of BPH.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Market Report Segmentation
By Laser Type- Holmium Laser System
- Thulium Laser System
- Diode Laser System
- Others
- Benign Prostatic Hyperplasia (BPH)
- Urolithiasis
- Non-Muscle-Invasive Bladder Cancer (NMIBC)
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Urology Laser Market by Laser Type
Chapter 5. Europe Urology Laser Market by Application
Chapter 6. Europe Urology Laser Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Methodology
LOADING...
